Important notice

Warning – Fraudulent Calls

Several persons have received fraudulent calls impersonating RAMQ. If you do not have a pending request with us or if the call seems suspicious, do not provide any personal information. Make a note of the agent’s name, end the conversation and call us. To find out more, refer to Our communication practices webpage.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4857 results found.

Example of search result explained

M-Febuxostat

Exceptional medication
  • Active ingredient(s):
    febuxostat
  • Manufactured by:
    Mantra Pharma inc. (Mantra Ph.)
  • Strength and dosage form:
    Tablet 80 mg DIN : 2549425

Uplizna

Exceptional medication
  • Active ingredient(s):
    inebilizumab
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    Intravenous Perfusion Solution 10 mg/mL (10 mL) DIN : 2543931

ratio-Lactulose

Exceptional medication
  • Active ingredient(s):
    lactulose
  • Manufactured by:
    Teva Canada Ltée (Teva Can)
  • Strength and dosage form:
    Oral Solution 667 mg/mL DIN : 854409

Jamteki

Exceptional medication
  • Active ingredient(s):
    ustekinumab (ulcerative colitis and Crohn's disease)
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 99114454
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 99114456
    • Intravenous Perfusion Solution 5 mg/mL (26 mL) DIN : 2553120
    • Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 99114452

Jamteki

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis children)
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 99114455
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 99114457
    • Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 99114453

Evkeeza

Exceptional medication
  • Active ingredient(s):
    evinacumab
  • Manufactured by:
    Ultragenyx (Ultragenyx)
  • Strength and dosage form:
    Intravenous Perfusion Solution 150 mg/mL (2,3 mL) DIN : 2541769

Ajovy

Exceptional medication
  • Active ingredient(s):
    fremanezumab
  • Manufactured by:
    Teva Canada Innovation (Teva Innov)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 150 mg/mL (1,5 mL) DIN : 2497859
    • Subcutaneous Injectable Solution (pen) 150 mg/mL (1,5 mL) DIN : 2509474

Fruzaqla

Exceptional medication
  • Active ingredient(s):
    fruquintinib
  • Manufactured by:
    Takeda Canada Inc. (Takeda)
  • Strength and dosage form:
    • Capsule 1 mg DIN : 2551454
    • Capsule 5 mg DIN : 2551462

Emgality

Exceptional medication
  • Active ingredient(s):
    galcanézumab
  • Manufactured by:
    Eli Lilly Canada Inc. (Lilly)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 120 mg/mL (1 mL) DIN : 2491060
    • Subcutaneous Injectable Solution (pen) 120 mg/mL (1 mL) DIN : 2491087

Reddy-Nilotinib

Exceptional medication
  • Active ingredient(s):
    nilotinib
  • Manufactured by:
    Dr Reddy's Laboratories Canada Inc (Dr Reddy's)
  • Strength and dosage form:
    • Capsule 150 mg DIN : 2556634
    • Capsule 200 mg DIN : 2556642
Page 139 of 486

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.